FIBROBLAST GROWTH FACTOR 23 IN PREGNANT RATS WITH DIFFERENT VITAMIN D3 STATUS

Poladych I. V.

FIBROBLAST GROWTH FACTOR 23 IN PREGNANT RATS WITH DIFFERENT VITAMIN D3 STATUS


Show/Download

About the author:

Poladych I. V.

Heading:

CLINICAL AND EXPERIMENTAL MEDICINE

Type of article:

Scientific article

Annotation:

Vitamin D₃ deficiency during pregnancy is associated with impaired calcium-phosphorus homeostasis and the development of gestational complications. Fibroblast growth factor 23 (FGF23), a peptide hormone that regulates phosphate metabolism and active vitamin D3 synthesis, may play a critical role in these processes. However, its systemic and placental activity during pregnancy remains poorly understood. The aim is to investigate FGF23 levels in the serum and placenta of pregnant rats with different vitamin D3 statuses and to analyze its associations with key biomarkers of mineral metabolism. This study included 36 pregnant Wistar rats divided into three groups: control, vitamin D₃-deficient, and D₃-corrected with cholecalciferol. Serum and placental levels of 25(OH)D₃ and FGF23 were measured using ELISA. Statistical analysis was performed with ANOVA and correlation tests. In rats with vitamin D₃ deficiency, serum FGF23 levels were significantly increased (471.7 ± 20.4 pg/mL) com- pared to the control group (211.5 ± 15.82 pg/mL; p<0.001). Correction with cholecalciferol reduced the level to 173.4 ± 12.5 pg/mL (p<0.001). Placental FGF23 showed a slight increase in the deficiency group, though differences were not statistically significant. FGF23 levels negatively correlated with 25(OH)D3 (r= -0.75) and positively with PTH (r=0.62). FGF23 responds to vitamin D₃ deficiency by increasing systemic levels and may contribute to mineral imbalance during pregnancy. Its normalization after D₃ correction suggests potential as a biomarker of gestational disturbances linked to mineral metabolism.

Tags:

FGF23, obstetric complications, phosphate metabolism, placenta, pregnancy, rats, вітамін D₃

Bibliography:

  1. Kiely ME, Wagner CL, Roth DE. Vitamin D in pregnancy: Where we are and where we should go. J Steroid Biochem Mol Biol. 2020;201:105669. DOI: 10.1016/j.jsbmb.2020.105669.
  2. Ni M, Zhang Q, Zhao J, Shen Q, Yao D, Wang T, et al. Relationship between maternal vitamin D status in the first trimester of pregnancy and maternal and neonatal outcomes: a retrospective single center study. BMC Pediatr. 2021;21(1):330. DOI: 10.1186/s12887-021-02730-z.
  3. Morales-Suárez-Varela M, Uçar N, Soriano JM, Llopis-Morales A, Sanford BS, Grant WB. Vitamin D-Related Risk Factors for Maternal Morbidity and Mortality during Pregnancy: Systematic Review and Meta-Analysis. Nutrients. 2022;14(19):4124. DOI: 10.3390/nu14194124.
  4. Fischer PR, Almasri NI. Nutritional rickets-Vitamin D and beyond. J. Steroid Biochem. Mol. Biol. 2022;219:106070. DOI: 10.1016/j.jsbmb.2022.106070.
  5. Salles JP. Bone metabolism during pregnancy. Ann Endocrinol (Paris). 2016;77(2):163-8. DOI: 10.1016/j.ando.2016.04.004.
  6. Mansur JL, Oliveri B, Giacoia E, Fusaro D, Costanzo PR. Vitamin D: Before, during and after Pregnancy: Effect on Neonates and Children. Nutrients. 2022;14(9):1900. DOI: 10.3390/nu14091900.
  7. Mao D, Yuen LY, Ho CS, Wang CC, Tam CH, Chan MH, et al. The Association of Prenatal Vitamin D Status With Pregnancy and Neonatal Outcomes. J Endocr Soc. 2023;8(1):bvad142. DOI: 10.1210/jendso/bvad 142.
  8. Benachi A, Baptiste A, Taieb J, Tsatsaris V, Guibourdenche J, Senat MV, et al. Relationship between vitamin D status in pregnancy and the risk for preeclampsia: A nested case-control study. Clin Nutr. 2020;39(2):440-446. DOI: 10.1016/j.clnu.2019.02.015.
  9. Carmeliet G, Bouillon R. How Important Is Vitamin D for Calcium Homeostasis During Pregnancy and Lactation? J Bone Miner Res. 2018;33(1):13-15. DOI: 10.1002/jbmr.3344.
  10. Fleet JC. Vitamin D-Mediated Regulation of Intestinal Calcium Absorption. Nutrients. 2022;14(16):3351. DOI: 10.3390/nu14163351.
  11. Poladych IV. Vitamin D in the genesis of preeclampsia: current understanding of the problem (literature review). Bulletin of problems biology and medicine. 2024;175(4):113-122. DOI: 10.29254/2077-4214-2024-4-175-113-122
  12. Ashley B, Simner C, Manousopoulou A, Jenkinson C, Hey F, Frost JM, et al. Placental uptake and metabolism of 25(OH)vitamin D determine its activity within the fetoplacental unit. Elife. 2022;11:e71094. DOI: 10.7554/eLife.71094.
  13. Aguilar-Cordero MJ, Lasserrot-Cuadrado A, Mur-Villar N, León-Ríos XA, Rivero-Blanco T, Pérez-Castillo IM. Vitamin D, preeclampsia and prematurity: A systematic review and meta-analysis of observational and interventional studies. Midwifery. 2020;87:102707. DOI:10.1016/j.midw. 2020.102707.
  14. Dahma G, Neamtu R, Nitu R, Gluhovschi A, Bratosin F, Grigoras ML, et al. The Influence of Maternal Vitamin D Supplementation in Pregnancies Associated with Preeclampsia: A Case-Control Study. Nutrients. 2022;14(15):3008. DOI: 10.3390/nu14153008.
  15. Raia-Barjat T, Sarkis C, Rancon F, Thibaudin L, Gris JC, Alfaidy N, et al. Vitamin D deficiency during late pregnancy mediates placenta- associated complications. Sci Rep. 2021;11(1):20708. DOI: 10.1038/s41598-021-00250-5.
  16. Varshney S, Adela R, Kachhawa G, Dada R, Kulshreshtha V, Kumari R, et al. Disrupted placental vitamin D metabolism and calcium signaling in gestational diabetes and pre-eclampsia patients. Endocrine. 2023;80(1):191-200. DOI: 10.1007/s12020-022-03272-9.
  17. Saki F, Sadeghian F, Kasaee SR, Koohpeyma F, Ranjbar Omrani GH. Effect of prolactin and estrogen on the serum level of 1,25-dihydroxy vitamin D and FGF23 in female rats. Arch Gynecol Obstet. 2020;302(1):265-271. DOI: 10.1007/s00404-020-05567-6.
  18. Razzaque MS. Interactions between FGF23 and vitamin D. Endocr Connect. 2022;11(10):e220239. DOI: 10.1530/EC-22-0239.
  19. Wu W, Fan H, Jiang Y, Liao L, Li L, Zhao J, et al. Regulation of 25-hydroxyvitamin D-1-hydroxylase and 24-hydroxylase in keratinocytes by PTH and FGF23. Exp Dermatol. 2018;27(11):1201-1209. DOI: 10.1111/exd.13760.
  20. Latic N, Erben RG. Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin- Angiotensin-Aldosterone System. Nutrients. 2022;14(23):5186. DOI: 10.3390/nu 14235186.
  21. Saki F, Kasaee SR, Sadeghian F, Koohpeyma F, Omrani GHR. Investigating the effect of testosterone by itself and in combination with letrozole on 1,25-dihydroxy vitamin D and FGF23 in male rats. J Endocrinol Invest. 2019;42(1):19-25. DOI: 10.1007/s40618-018-0875-3.
  22. Bøllehuus Hansen L, Kaludjerovic J, Nielsen JE, Rehfeld A, Poulsen NN, Ide N, et al. Influence of FGF23 and Klotho on male reproduction: Systemic vs direct effects. FASEB J. 2020;34(9):12436-12449. DOI: 10.1096/fj.202000061RR.
  23. Dastghaib S, Koohpeyma F, Shams M, Saki F, Alizadeh A. New concepts in regulation and function of the FGF23. Clin Exp Med. 2023;23(4):1055-1066. DOI: 10.1007/s10238-022-00844-x.
  24. Bär L, Feger M, Fajol A, Klotz LO, Zeng S, Lang F, et al. Insulin suppresses the production of fibroblast growth factor 23 (FGF23). Proc Natl Acad Sci U S A. 2018;115(22):5804-5809. DOI: 10.1073/pnas.1800160115.
  25. Ryan BA, Alhani K, Sellars KB, Kirby BJ, St-Arnaud R, Kaufmann M, et al. Mineral Homeostasis in Murine Fetuses Is Sensitive to Maternal Calcitriol but Not to Absence of Fetal Calcitriol. J Bone Miner Res. 2019;34(4):669-680. DOI: 10.1002/jbmr.3642.
  26. Maekawa AS, Bennin D, Hartery SA, Kirby BJ, Poulton IJ, St-Arnaud R, et al. Maternal loss of 24-hydroxylase causes increased intestinal calcium absorption and hypercalcemia during pregnancy but reduced skeletal resorption during lactation in mice. J Bone Miner Res. 2024;39(12):1793-1808. DOI: 10.1093/jbmr/zjae166.

Publication of the article:

«Bulletin of problems biology and medicine», 2025 Issue 3,178, 213-220 pages, index UDC 612.015.3:616-092.9-008.6:577.17](083.1)

DOI:

10.29254/2077-4214-2025-3-178-213-220

Was this article helpful?

Leave a Reply

Your email address will not be published. Required fields are marked *


The reCAPTCHA verification period has expired. Please reload the page.